HR 5429 · 118th Congress · Commerce
Medication Affordability and Patent Integrity Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2023-09-15)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 5429 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 5429 To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 13, 2023 Ms. Kuster (for herself and Mrs. Harshbarger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Be it enacted by the Senate and House of Re…
Summarized by Claude AI · Non-partisan · For informational purposes only